← Back to Search

Pre-Treatment Physical Therapy for Acoustic Neuroma (VS PREHAB Trial)

N/A
Recruiting
Led By Michael Harris, MD
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Initial diagnosis of a Vestibular Schwannoma confirmed by a physician with an internal auditory canal (IAC) MRI, in accordance with standard or institutional practice
Eastern Cooperative Oncology Group (ECOG) Performance Status <2
Must not have
Prior treatment of VS including radiotherapy or surgery or treatment for disease recurrence or planned salvage procedure
Anticipated radiation other than stereotactic (fractionated)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment 12 months

Summary

This trial will measure balance in patients with Vestibular Schwannomas before and after treatment with surgery or radiotherapy with or without physical therapy.

Who is the study for?
Adults diagnosed with Vestibular Schwannoma (VS) of size ≤2.5 cm, confirmed by MRI, who will undergo surgery or radiosurgery. Participants must be in good health as determined by normal lab values and have an ECOG Performance Status <2. Pregnant women or those not using effective contraception are excluded.
What is being tested?
The trial is testing the effectiveness of pre-treatment vestibular physical therapy (PREHAB) on balance for patients with VS undergoing microsurgical resection or stereotactic radiosurgery compared to no PREHAB.
What are the potential side effects?
Potential side effects may include discomfort from physical therapy exercises, typical surgical risks like infection or bleeding for those undergoing resection, and common radiosurgery side effects such as headaches, nausea, and fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My doctor confirmed I have a Vestibular Schwannoma with an MRI.
Select...
I can do all or most of my daily activities without help.
Select...
My tumor is 2.5 cm or smaller and will be treated with surgery or stereotactic radiosurgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had treatment for my VS, including surgery or radiotherapy.
Select...
I am expected to receive radiation therapy that is not stereotactic.
Select...
I do not have health issues like stroke or severe vision problems that affect my balance.
Select...
I have a diagnosed balance disorder like Meniere's or BPPV.
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sensory Organization Test Score at Post-Treatment Assessments

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Intervention: PREHAB and SurgeryActive Control2 Interventions
PREHAB exercises will be determined during the physical therapy visit (1x/week) and completed daily with varying frequency for three weeks. Subjects will undergo microsurgical resection of VS.
Group II: Intervention: PREHAB and SRSActive Control2 Interventions
PREHAB exercises will be determined during the physical therapy visit (1x/week) and completed daily with varying frequency for three weeks. Subjects will undergo stereotactic radiosurgery.
Group III: Control: Surgery (No PREHAB)Placebo Group1 Intervention
Subjects will undergo microsurgical resection of VS.
Group IV: Control: SRS (No PREHAB)Placebo Group1 Intervention
Subjects will undergo stereotactic radiosurgery.

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
631 Previous Clinical Trials
1,181,922 Total Patients Enrolled
Michael Harris, MDPrincipal InvestigatorMedical College of Wisconsin

Media Library

Microsurgical resection of VS Clinical Trial Eligibility Overview. Trial Name: NCT05702749 — N/A
Acoustic Neuroma Clinical Trial 2023: Microsurgical resection of VS Highlights & Side Effects. Trial Name: NCT05702749 — N/A
Acoustic Neuroma Research Study Groups: Intervention: PREHAB and Surgery, Control: Surgery (No PREHAB), Intervention: PREHAB and SRS, Control: SRS (No PREHAB)
Microsurgical resection of VS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05702749 — N/A
~24 spots leftby Jul 2027